Form 4: Guardant Health Director, Manuel Hidalgo Medina, Reports Stock Option and Restricted Stock Unit Grants

Manuel Hidalgo Medina, a director of Guardant Health, Inc., reported the acquisition of stock options and restricted stock units on July 17, 2024.

Summary

• On July 17, 2024, Manuel Hidalgo Medina, a director of Guardant Health, Inc., was granted stock options to purchase 17,029 shares of common stock at an exercise price of $32.55.
• These options vest over a four-year period, with 25% vesting on the one-year anniversary of the grant date and the remaining 75% vesting monthly over the subsequent three years.
• Medina also received 11,137 restricted stock units (RSUs) which also vest over a four-year period with the same vesting schedule as the stock options.
• Following these transactions, Medina directly owns 17,029 stock options and 11,137 RSUs.

Sentiment

Score: 6

Explanation: The document itself is neutral, simply reporting the grant of stock options and RSUs. It's a standard practice, so neither particularly positive nor negative.

Positives

• The grant of stock options and RSUs to a director aligns their interests with those of the shareholders, incentivizing them to work towards the company's long-term success.

Future Outlook

The document does not contain any specific forward-looking statements regarding the company's future performance.

Industry Context

Stock options and restricted stock units are common forms of executive compensation in the biotechnology industry, used to attract and retain talent and align their interests with those of shareholders.

Comparison to Industry Standards

• Stock option and RSU grants are standard practice for compensating directors and executives in publicly traded companies, particularly in the biotech sector.
• The vesting schedule of four years with a one-year cliff is also a common arrangement.
• Comparable companies like Exact Sciences or Illumina also utilize similar equity-based compensation plans for their directors.

Stakeholder Impact

• The grant of equity to a director can positively impact shareholders by aligning management's interests with theirs.
• Employees may view this as a positive sign of the company's commitment to its leadership.

Key Dates